Trials / Terminated
TerminatedNCT01557842
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Biosense Webster, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if early ablation (i.e., ablation of ventricular tachycardia in patients with infrequent VT episodes) is more effective than medical therapy alone for the treatment of ischemic ventricular tachycardia in patients with Implantable Cardioverter Defibrillators (ICDs) who continue to have episodes of ventricular tachycardia despite drug therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Drug Treatment | Class I and III antiarrhythmic drug treatment. |
| DEVICE | Catheter Ablation | Radiofrequency catheter ablation and Class I and III antiarrhythmic drug treatment. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-03-19
- Completion
- 2014-03-19
- First posted
- 2012-03-20
- Last updated
- 2017-06-08
- Results posted
- 2015-01-01
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01557842. Inclusion in this directory is not an endorsement.